Aaron Bloomer
Chief Financial Officer at Resmed Inc (RMD) since May 2026
Aaron Bloomer has filed 9 insider reports with the SEC since May 2024, as chief Financial Officer at Resmed Inc (RMD) and EVP and chief Financial Officer at Exact Sciences Corp (EXAS). The latest filing, on November 13, 2026, reports shares withheld for taxes or exercise price at Resmed Inc (RMD).
- Filings
- 9
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Aaron Bloomer is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Financial Officersince May 2026 | 7,977 | $235.63 | Nov 13, 2026 | ||||
| EVP, Chief Financial Officersince May 2024 | 0 | Mar 23, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 11, 2026RMDChief Financial Officer Bloomer Aaron covered exercise/tax liability with 1,095 units of ResMed Common Stock, decreasing direct ownership by 12% to 7,977 units to satisfy withholding taxForm 4Shares withheld for taxes or exercise price
- Aug 14, 2026RMDChief Financial Officer Bloomer Aaron was granted 9,072 units of ResMed Common StockForm 4Grant or award
- May 4, 2026RMDAaron Bloomer became an insiderForm 3New insider
- Mar 23, 2026EXASSEC Form 4 filed by Bloomer AaronForm 4Grant or awardSale back to the company
- Feb 25, 2026EXASSEC Form 4 filed by EVP, Chief Financial Officer Bloomer AaronForm 4Grant or award
- Dec 23, 2025EXASEVP, Chief Financial Officer Bloomer Aaron converted options into 63,099 shares and covered exercise/tax liability with 27,954 shares, increasing direct ownership by 258% to 48,768 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Apr 15, 2025EXASEVP, Chief Financial Officer Bloomer Aaron converted options into 24,460 shares and covered exercise/tax liability with 10,837 sharesForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 24, 2025EXASSEC Form 4 filed by EVP, Chief Financial Officer Bloomer AaronForm 4Grant or award
Compare Aaron Bloomer with
- Aaron Bloomer vs Michael J. Farrell1 shared
- Aaron Bloomer vs Christopher DelOrefice1 shared
- Aaron Bloomer vs Michael J Rider1 shared
- Aaron Bloomer vs Ronald R Taylor1 shared
- Aaron Bloomer vs Harjit Gill1 shared
- Aaron Bloomer vs Desney Tan1 shared
Other insiders at the same companies
- Michael J. FarrellRMD
- Christopher DelOreficeRMD
- Michael J RiderRMD
- Ronald R TaylorRMD
- Harjit GillRMD
- Desney TanRMD
- John HernandezRMD
- Karen DrexlerRMD
- Justin LeongRMD
- Carol BurtRMD
- Peter C FarrellRMD
- Jan De WitteRMD
- Brett SandercockRMD
- Brian BaranickEXAS
- James HerriottEXAS
- Sarah CondellaEXAS
Questions about Aaron Bloomer
- What is Aaron Bloomer's role at Resmed Inc?
- Aaron Bloomer reports to the SEC as chief Financial Officer at Resmed Inc (RMD), according to the latest filing on November 13, 2026. Aaron Bloomer has also filed as EVP and chief Financial Officer at Exact Sciences Corp (EXAS).
- How many shares does Aaron Bloomer own?
- After the latest filing that states it, Aaron Bloomer directly owned 7,977 shares of Resmed Inc (RMD). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Aaron Bloomer bought or sold stock recently?
- No open-market purchases or sales by Aaron Bloomer are on file. The filings report shares withheld for taxes or exercise price, grant or award, sale back to the company and exercise or conversion of a derivative.
- How do I get alerts when Aaron Bloomer files?
- Follow Aaron Bloomer on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Aaron Bloomer filed 2 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Aaron Bloomer (SEC CIK 0002019003). Totals count each trade once, skipping amendments whose original is on file, from May 20, 2024 on. View on SEC EDGAR · Get this as JSON